U. S. Securities and Exchange Commission
                         Washington, D. C.  20549

                                FORM 10-QSB


[X]  QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES
     EXCHANGE ACT OF 1934

     For the quarterly period ended September 30, 2005

[ ]  TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES
     EXCHANGE ACT OF 1934

     For the transition period from                to
                                    --------------    ---------------

                     Commission File No.  000-31377

                          REFLECT SCIENTIFIC, INC.
                          ------------------------
              (Name of Small Business Issuer in its Charter)

             UTAH                                      87-0642556
             ----                                      ----------
  (State or Other Jurisdiction of              (I.R.S. Employer I.D. No.)
 incorporation or organization)

                          970 Terra Bella Avenue
                     Mountain View, California, 94043
                     --------------------------------
                  (Address of Principal Executive Offices)

                 Issuer's Telephone Number:  (650) 960-0300
                                             --------------

Indicate by check mark whether the Registrant (1) has filed all reports
required to be filed by Sections 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
Registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days.

(1)  Yes  X     No                 (2)  Yes  X    No
         ---     ---                        ---     ---

Indicate by check mark whether the Registrant is a shell company (as defined
in Rule 12b-2 of the Exchange Act).  Yes     No X
                                        ---    ---

<PAGE>
             APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY
                PROCEEDINGS DURING THE PRECEDING FIVE YEARS

                              Not applicable.

                   APPLICABLE ONLY TO CORPORATE ISSUERS

Indicate the number of shares outstanding of each of the Registrant's classes
of common stock, as of the latest practicable date:

                            September 30, 2005

                                24,380,000
                                ----------

                      PART I - FINANCIAL INFORMATION

Item 1.   Financial Statements.
-------------------------------

          The Financial Statements of the Company required to be filed with
this 10-QSB Quarterly Report were prepared by management, and commence on the
following page, together with Related Notes.  In the opinion of management,
the Financial Statements fairly present the financial condition of the
Company.
<PAGE>
                    REFLECT SCIENTIFIC, INC.

                CONSOLIDATED FINANCIAL STATEMENTS

             September 30, 2005 and December 31, 2004
<PAGE>
                    REFLECT SCIENTIFIC, INC.
                   Consolidated Balance Sheets

                              ASSETS

                                            September 30,        December 31,
                                                2005                2004
                                             (Unaudited)
CURRENT ASSETS

     Cash                                     $   461,586      $    80,739
     Accounts receivable, net                     335,302          281,173
     Inventory, net                               353,145          260,012
     Prepaid expenses                                 800              800
                                              -----------      -----------
          Total Current Assets                  1,150,833          622,724
                                              -----------      -----------
FIXED ASSETS (NET)                                 21,775           24,249
                                              -----------      -----------
OTHER ASSETS

     Deposits                                       5,350            5,350
     Capitalized loan costs, net                    4,900            5,600
                                              -----------      -----------
          Total Other Assets                       10,250           10,950
                                              -----------      -----------
          TOTAL ASSETS                        $ 1,182,858      $   657,923
                                              ===========      ===========

The accompanying notes are an integral part of these consolidated financial
statements.
                                2
<PAGE>
                    REFLECT SCIENTIFIC, INC.
             Consolidated Balance Sheets (Continued)


               LIABILITIES AND SHAREHOLDERS' EQUITY

                                            September 30,        December 31,
                                                2005                2004
                                             (Unaudited)
CURRENT LIABILITIES

     Accounts payable                         $    185,584     $    131,610
     Accrued expenses                               10,656           23,955
     Income taxes payable                           30,705           30,705
                                              ------------     ------------
          Total Current Liabilities                226,945          186,270
                                              ------------     ------------
NON-CURRENT LIABILITIES

     Long term line of credit                            -          269,036
     Deferred income taxes                          39,000           39,000
                                              ------------     ------------
          Total Non-Current Liabilities             39,000          308,036
                                              ------------     ------------
          Total Liabilities                        265,945          494,306
                                              ------------     ------------
COMMITMENTS AND CONTINGENCIES

SHAREHOLDERS' EQUITY

     Preferred stock, $0.01 par value,
     authorized 5,000,000 shares, 700,000
     shares issued and outstanding                   7,000                -
     Common stock, $0.01 par value, authorized
     50,000,000 shares; 24,380,000 shares
     issued and outstanding                        243,800          240,000
     Additional paid-in capital (deficit)          514,937         (183,319)
     Retained earnings                             151,176          106,936
                                             -------------     ------------
          Total Shareholders' Equity               916,913          163,617
                                             -------------     ------------
          TOTAL LIABILITIES AND SHAREHOLDERS'
          EQUITY                             $   1,182,858     $    657,923
                                             =============     ============

The accompanying notes are an integral part of these consolidated financial
statements.
                                3
<PAGE>
                    REFLECT SCIENTIFIC, INC.
              Consolidated Statements of Operations
                           (Unaudited)


                          For the Three Months Ended For the Nine Months Ended
                                September 30,               September 30,
                           2005                2004     2005            2004

REVENUES                    $ 573,572     $ 522,600   $ 1,628,313 $1,604,307

COST OF GOODS SOLD            326,041       319,435       919,883    963,470
                             --------     ---------   ----------- ----------
GROSS PROFIT                  247,531       203,165       708,430    640,837
                             --------     ---------   ----------- ----------
OPERATING EXPENSES

     Salaries and wages        88,784        87,091       250,131    263,273
     Payroll taxes              7,803         7,127        21,416     22,558
     Rent expense              21,454        19,306        59,761     57,364
     General and
      administrative expense   72,490        88,127       322,921    226,295
                             --------     ---------   ----------- ----------
   Total Operating Expenses   190,531       201,648       654,229    569,487
                             --------     ---------   ----------- ----------
OPERATING INCOME               57,000         1,517        54,201     71,350
                             --------     ---------   ----------- ----------
OTHER INCOME (EXPENSE)

     Sundry income                  -             -             -      5,000
     Miscellaneous expense          -             -             -       (301)
     Interest expense          (1,583)       (3,051)       (9,961)    (8,759)
                             --------     ---------   ----------- ----------
          Total Other Income
          (Expense)            (1,583)       (3,051)       (9,961)    (4,060)
                             --------     ---------   ----------- ----------
NET INCOME (LOSS) BEFORE
INCOME TAX                     55,417        (1,534)       44,240     67,290
                             --------     ---------   ----------- ----------
INCOME TAX EXPENSE                  -             -             -     13,200

NET INCOME                   $ 55,417     $  (1,534)  $    44,240 $   54,090
                             ========     =========   =========== ==========
Preferred distribution,
dividends                    (108,054)            -      (700,000)         -

NET INCOME (LOSS) PER SHARE
APPLICABLE TO COMMON
SHAREHOLDERS                $ (52,637)    $  (1,534)  $  (655,759)$   54,090
                            =========     =========   =========== ==========
EARNINGS PER SHARE          $    0.00     $   (0.00)  $      0.00 $     0.00
                             ========     =========   =========== ==========
WEIGHTED AVERAGE NUMBER OF
SHARES OUTSTANDING           24,380,000  24,000,000    24,204,615 24,000,000
                             ==========  ==========   =========== ==========

The accompanying notes are an integral part of these consolidated financial
statements.
                                4
<PAGE>
                    REFLECT SCIENTIFIC, INC.
         Consolidated Statements of Shareholders' Equity


                                                        Additional
                      Common Stock     Preferred Stock   Paid-in    Retained
                    Shares      Amount  Shares  Amount   Capital    Earnings
Balance,
December 31, 2004  24,000,000   240,000       -       -   (183,319)   106,936

Preferred stock
issued for cash
(unaudited)                 -         - 436,000   4,360    431,640          -

Preferred stock
issued for cash
(unaudited)                 -         - 264,000   2,640    261,360          -

Common stock
issued for services
(unaudited)           380,000     3,800       -       -      5,256          -

Net income for the
nine months ended
September 30, 2005
(unaudited)                 -         -       -       -          -     44,240
                   ----------  -------- -------  ------  --------- ----------
Balances,
September 30, 2005
(unaudited)        24,380,000  $243,800 700,000  $7,000  $ 514,937 $  151,176
                   ==========  ======== =======  ======  ========= ==========

The accompanying notes are an integral part of these consolidated financial
statements.
                                5
<PAGE>
                    REFLECT SCIENTIFIC, INC.
              Consolidated Statements of Cash Flows
                           (Unaudited)

                                        For the Nine Months Ended
                                             September 30,
                                          2005                2004
CASH FLOWS FROM OPERATING ACTIVITIES

     Net income                           $    44,240     $    54,090
     Adjustments to reconcile net income
      to net cash provided by operating
      activities:
          Depreciation                          2,474           1,676
          Amortization of capitalized loan
          costs                                   700             350
          Common stock issued for services      9,056               -
     Changes in operating assets and
     liabilities:
         (Increase) in accounts receivable    (54,129)        (86,666)
         (Increase) in inventory              (93,133)        (31,079)
         Increase (decrease) in accounts
          payable and accrued expenses         40,675         (26,124)
                                           ----------     -----------
               Net Cash (Used) by Operating
               Activities                     (50,117)        (87,753)

CASH FLOWS FROM INVESTING ACTIVITIES

CASH FLOWS FROM FINANCING ACTIVITIES

     Change in long term line of credit      (269,036)            (25)
     Contributed capital                            -          22,522
     Proceeds from preferred stock issuance   700,000               -
                                           ----------     -----------
               Net Cash Provided by
               Financing Activities           430,964          22,497
                                           ----------     -----------
NET (INCREASE) DECREASE IN CASH               380,847         (65,256)

CASH AT BEGINNING OF PERIOD                    80,739          99,924
                                           ----------     -----------
CASH AT END OF PERIOD                      $  461,586     $    34,668
                                           ==========     ===========

NON-CASH INVESTING AND FINANCING ACTIVITIES:

     Cash Paid For:

          Interest                         $    9,961     $     3,051
          Income taxes                     $        -     $         -


The accompanying notes are an integral part of these consolidated financial
statements.
                                6
<PAGE>
                    REFLECT SCIENTIFIC, INC.
          Notes to the Consolidated Financial Statements
            September 30, 2005 and December 31, 2004

NOTE 1 -  BASIS OF FINANCIAL STATEMENT PRESENTATION

     The accompanying unaudited condensed consolidated financial statements
     have been prepared by the Company pursuant to accounting principles
     generally accepted in the United States of America. Certain information
     and footnote disclosures normally included in financial statements
     prepared in accordance with accounting principles generally accepted in
     the United States of America have been condensed or omitted in
     accordance with such rules and regulations.  The information furnished
     in the interim condensed consolidated financial statements include
     normal recurring adjustments and reflects all adjustments, which, in the
     opinion of management, are necessary for a fair presentation of such
     financial statements.  Although management believes the disclosures and
     information presented are adequate to make the information not
     misleading, it is suggested that these interim condensed consolidated
     financial statements be read in conjunction with the Company's most
     recent audited consolidated financial statements and notes thereto
     included in its December 31, 2004 financial statements.  Operating
     results for the nine months ended September 30, 2005 are not necessarily
     indicative of the results that may be expected for the year ending
     December 31, 2005.

NOTE 2 -  ACQUISITION OF REFLECT SCIENTIFIC

     On December 30, 2003, pursuant to an agreement and plan of
     reorganization, the Company completed a reverse merger with the
     shareholder of Reflect Scientific, Inc. in which it acquired 100% of
     Reflect Scientific, Inc., a California Company in exchange for
     22,914,949 common shares of the Company.  The terms of the acquisition
     are detailed in an 8-K filing dated December 31, 2003.  Under the terms
     of the agreement, the President of Reflect Scientific, Inc. became the
     President of the Company and was elected to the Board of Directors, the
     acquisition was accounted for as a recapitalization of Reflect
     Scientific, Inc. because the members of Reflect Scientific, Inc.
     controlled the Company after the acquisition.  Reflect Scientific, Inc.
     was treated as the acquiring entity for accounting purposes and Cole,
     Inc. was the surviving entity for legal purposes.  There was no
     adjustment to the carrying values of the assets or liabilities of
     Reflect Scientific, Inc. and no goodwill was recorded.

NOTE 3   EQUITY TRANSACTIONS

     Dividends

     The holders of the Series A Preferred Stock are entitled to dividends at
     the rate of 8 percent per year of the liquidation preference of $1.00
     per share, payable annually, if and when declared by the board of
     directors. Dividends are not cumulative and the board of directors are
     under no obligation to declare dividends.

     Convertibility

     Upon the approval of the Board of Directors, Series A Preferred Stock
     may be convertible into the Company's common stock by dividing $1.00
     plus any unpaid dividends by 50% of the five day average closing bid
     price of the common shares. The Company's board of directors has
     subsequently voted to amend the terms of the conversion price of the
     Series A Preferred Stock to be %0.60 per share.

     During the period the Company sold 700,000 shares of Series A
     Convertible Preferred Stock in exchange for proceeds of $700,000. As a
     result of the beneficial conversion feature inherent in the conversion
     rights and preferences of Series A Preferred Stock, the Company has
     recognized a deemed dividend of $700,000. This deemed dividend was
     calculated based on the conversion price above at the time of
     conversion. Because the Company does not have sufficient retained
     earnings, dividends were recorded in additional paid-in-capital and have
     a net affect of zero in that account and is therefore not presented on
     the statement of shareholders' equity as a separate item.  This
     beneficial conversion feature was recorded to additional paid in capital
     and will be recorded as a deemed dividend to preferred shareholders
     (accretion) over the period to the instruments earliest conversion date.
     This date was July 19, 2005.  Subsequent to September 30, 2005, and as of
     the date of this report, holders of the preferred shares have converted
     all 700,000 shares into 1,166,667 shares of common stock.
                                7
<PAGE>

Item 2.   Management's Discussion and Analysis or Plan of Operation.
--------------------------------------------------------------------

Results of Operations.
----------------------

          Our revenues increased during the quarter ended September 30, 2005,
to $573,572, from $522,600 for the quarter ended September 30, 2004, primarily
as a result of a general improvement in sales across several product lines.

          Our cost of goods increased in the quarter ended September 30, 2005,
as compared to September 30, 2004, to $326,041 from $319,435, as a result of
increased raw material costs and increased sales.

          General and administrative expenses decreased to $72,490 during the
quarter ended September 30, 2005, from $88,127 during the quarter ended
September 30, 2004.  This decrease was due to a reduction in research and
development expenses.

          Our revenues increased during the nine months ended September 30,
2005, to $1,628,313, from $1,604,307 for the nine months ended September 30,
2004, again primarily as a result of increased sales across several product
lines.

          Our cost of goods decreased in the nine months ending September 30,
2005, as compared to September 30, 2004, to $919,883 from $963,470, as a
result of a one time inventory obsolescence write off that was taken in 2004.

          General and administrative expenses increased to $322,921 during the
nine months ended September 30, 2005, from $226,296 during the nine months
ended September 30, 2004.  This increase was due to increased operational
expenses, primarily legal and accounting expenses.

     Liquidity and Capital Resources.
     --------------------------------

          Our cash resources at September 30, 2005, were $461,586, with
accounts receivable of $335,302.  We have relied on revenues and lines of
credit for our cash resources; and have received gross proceeds of $700,000
during the first six months of 2005 from the sale of Series A Convertible
Preferred Stock at $1.00 per share.  At September 30, 2005, we had paid off
our line of credit.  These funds should be adequate for the next 12 months for
continuing operations; however, plans for expansion will require additional
capital of between $500,000 and $750,000.

     Forward-Looking Statements.
     ---------------------------

         The Private Securities Litigation Reform Act of 1995 (the "Act")
provides a safe harbor for forward-looking statements made by or on behalf of
our Company.  Our Company and its representatives may from time to time make
written or oral statements that are "forward- looking," including statements
contained in this Quarterly Report and other filings with the Securities and
Exchange Commission and in reports to our Company's stockholders. Management
believes that all statements that express expectations and projections with
respect to future matters, as well as from developments beyond our Company's
control including changes in global economic conditions are forward-looking
statements within the meaning of the Act. These statements are made on the
basis of management's views and assumptions, as of the time the statements are
made, regarding future events and business performance. There can be no
assurance, however, that management's expectations will necessarily come to
pass.  Factors that may affect forward- looking statements include a wide
range of factors that could materially affect future developments and
performance, including the following:

         Changes in Company-wide strategies, which may result in changes in
the types or mix of businesses in which our Company is involved or chooses to
invest; changes in U.S., global or regional economic conditions, changes in
U.S. and global financial and equity markets, including significant interest
rate fluctuations, which may impede our Company's access to, or increase the
cost of, external financing for our operations and investments; increased
competitive pressures, both domestically and internationally, legal and
regulatory developments, such as regulatory actions affecting environmental
activities, the imposition by foreign countries of trade restrictions and
changes in international tax laws or currency controls; adverse weather
conditions or natural disasters, such as hurricanes and earthquakes, labor
disputes, which may lead to increased costs or disruption of operations.

         This list of factors that may affect future performance and the
accuracy of forward-looking statements is illustrative, but by no means
exhaustive.  Accordingly, all forward-looking statements should be evaluated
with the understanding of their inherent uncertainty.

Item 3. Controls and Procedures.
--------------------------------

          As of the end of the period covered by this Quarterly Report, we
carried out an evaluation, under the supervision and with the participation of
our President and Treasurer, of the effectiveness of our disclosure controls
and procedures.  Based on this evaluation, our President and Treasurer
concluded that our disclosure controls and procedures are effectively designed
to ensure that information required to be disclosed or filed by us is
recorded, processed or summarized, within the time periods specified in the
rules and regulations of the Securities and Exchange Commission.  It should be
noted that the design of any system of controls is based in part upon certain
assumptions about the likelihood of future events, and there can be no
assurance that any design will succeed in achieving its stated goals under all
potential future conditions, regardless of how remote.  In addition, we
reviewed our internal controls over financial reporting, and there have been
no changes in our internal controls or in other factors in the last fiscal
quarter that has materially affected or is reasonably likely to materially
affect our internal control over financial reporting.

                        PART II - OTHER INFORMATION

Item 1.   Legal Proceedings.
----------------------------

          None; not applicable.

Item 2.   Unregistered Sales of Equity Securities and Use of Proceeds.
----------------------------------------------------------------------

          2004 Convertible Preferred Stock.
          ---------------------------------

          As of the quarter ended June 30, 2005, we sold 700,000 shares of
our 2004 Series A Convertible Preferred Stock at an offering price of $1.00
per share to 26 persons who were "accredited investors" as that term in
defined in Regulation D of the Securities and Exchange Commission.
Subsequent to September 30, 2005, and as of the date of this Quarterly Report,
holders of the preferred shares have converted all 700,000 shares into
1,166,667 shares of common stock.

          We also issued 380,000 shares of common stock for services during
the quarter ended June 30, 2005, valued at $.0238 per share or $9,056.00.

          We issued all of these securities to persons who were either
"accredited investors," or "sophisticated investors" who, by reason of
education, business acumen, experience or other factors, were fully capable of
evaluating the risks and merits of an investment in our company; and each had
prior access to all material information about us.  We believe that the offer
and sale of these securities were exempt from the registration requirements of
the Securities Act, pursuant to Sections 4(2) and 4(6) thereof, and Rule 506
of Regulation D of the Securities and Exchange Commission and from various
similar state exemptions.

Item 3.   Defaults Upon Senior Securities.
------------------------------------------

          None; not applicable.

Item 4.   Submission of Matters to a Vote of Security Holders.
--------------------------------------------------------------

          None; not applicable.

Item 5.   Other Information.
----------------------------

          None; not applicable.

Item 6.   Exhibits.
-------------------

          Exhibits.

               31.1   302 Certification of Kim Boyce

               31.2   302 Certification of Kevin Cooksy

               32     906 Certification.

                               SIGNATURES

          Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this Report to be signed on its behalf by the
undersigned thereunto duly authorized.

                                          REFLECT SCIENTIFIC, INC.

Date: 11/10/05                            /s/Kim Boyce
                                          ------------------------------------
                                          Kim Boyce, President

Date: 11/10/05                            /s/Tom Tait
                                          ------------------------------------
                                          Tom Tait, Vice President


Date: 11/10/05                            /s/Kevin Cooksy
                                          ------------------------------------
                                          Kevin Cooksy, Secretary/Treasurer
<PAGE>